NCT04099732View on ClinicalTrials.gov

A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

Tablet

DRUG

BI 1358894

Tablet

DEVICE

Dabigatran etexilate

Capsule

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04099732 - A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood | Biotech Hunter | Biotech Hunter